Download - Qc Rp Kits (Mid Kfsh d)
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 1/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NML-4
99m
Tc-HDP
Procedure:
System I: ITLC-SG / Acetone (HPLC grade)
System II: ITLC-SG / Saline (0.! "aCl)
#$ere%
% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I.
% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System
II
% 99mTc-HDP & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate
(mTc*-) or%
& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-
$ydrolyed Tc (mTc-).
Results:
% 99mTc-HDP = 100 (%99mTcO4- ! %99mTcO2-)
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 2/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NML-4
99mTc-HDP
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH +adio$armacist
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 3/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM2
99mTc-D/*, Procedure:System I: ITLC-SG / et$yl 1t$yl 2eton (12)
System II: ITLC-SG / Saline (0.! "aCl)
#$ere%
% Pertechnetate (
99m
TcO4
-
) & ! acti'ity at t$e sol'ent ront in System I.% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System
II
% 99mTc-D/*, & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate
(mTc*-) or%
& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-
$ydrolyed Tc (mTc-).
Results:
% 99mTc-D/*, = 100 (%99mTcO4- ! %99mTcO2-)
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 4/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM2
99m
Tc-D/*,
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 5/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM3
99m
Tc-DTP, Procedure:System I: ITLC-SG / et$yl 1t$yl 2eton(12)
System II: ITLC-SG / Saline (0.! "aCl)
#$ere%
% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I.
% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System
II
% 99mTc-DTP, & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate
(mTc*-) or%
& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-
$ydrolyed Tc (mTc-).
Results:
% 99mTc-DTP, = 100 (%99mTcO4- ! %99mTcO2-)
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 6/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM3
99mTc-DTP,
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 7/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM5
99mTc-H+D, der$at$e
Procedure:Com3ination 3et4een t4o systems 4as ,sed or !+CP determination (UKRG, 2002)
as a modiication o t$e standard met$od introd,ced 3y Nunn et al (1983).
System I: #$atman 5 / 12 (6,tanone)
System II: ITLC-SG / 70! Acetonitril
N.B. The spotted sample in system I should be dried with a hot air stream or in an
oven with a temperature less than 50 0C (in higher temperature the sample may be
damaged) before developing the strip in the solvent.
#$ere%
% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I (+ & 0.).
% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System
II
% 99mTc-+D, & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate
(mTc*
Results:
% 99mTc-+D, = 100 (%99mTcO4- ! %99mTcO2-)
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 8/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM5
99mTc-H+D, der$at$eDate " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 9/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM6
99mTc-H/P,O Procedure:
+CP 4ere o3tained t$ro,g$ a com3ination o t$ree c$romatogra$ic systems t$at
allo4 t$e ,ll 8,antitati'e assessment o t$e radioc$emical comosition o t$e
mi9t,re.
T$ese systems are:
ITLC-SG / saline ("aCl) system
ITLC-SG / et$yl-et$yl eton
#$atman no.; / 70! Acetonitril: 70! H
T$en% ,sing t$ese t$ree c$romatogra$ic systems% t$e c$emical comosition o t$e
comle9 4as o3tained ,sing t$e ollo4ing relations$is:
% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in t$e ITLC-SG / "aCl
system.
% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in t$e
#$atman "o. ; / 70! Acetonitril: 70! H system.
% *econdary com#le' & ! acti'ity at + f & 0 < 0.5 in t$e ITLC/12 system < !
red,ced $ydrolyed Tc.% Pr$mary com#le' & ! acti'ity at + f & 0.5 < ; in t$e ITLC/12 system < !
ertec$netate.
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 10/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM6
99mTc-H/P,O
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 11/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM7
99mTc-/,,
Procedure:Proer aer c$romatogra$y roced,re can 3e ,sed to searate mTc-AA rom ree
ertec$netate. +T-* stris are ,sed as stationary $ase and ,cetone (HP
rade) as sol'ent.
#$ere%
% 99mTc-Pertechnetate & ! acti'ity at t$e sol'ent ront (+ & ;.0)
%99m
Tc-/,, and % Reduced-hydrolyzed Tc (99m
TcO2-
) = (! acti'ity remaining att$e origin (+ & 0.0).
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 12/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM7
99mTc-/,,
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 13/28
2
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA ProgramNM8
99mTc-/a3
Procedure:T4o c$romatogra$ic systems are ,sed to dierentiate 3et4een t$e t$ree ersisting secies
*ytem +" +T-* &thyl ,cetate-/&5 (3"2)
*ytem ++" +T-* 60% ,ceton$tr$l
#$ere%
% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I.
% Reduced-hydrolyzed Tc (99m
TcO2-
) & ! acti'ity remaining at t$e origin in System II% 99mTc-/,3 & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate ( mTc*-) or%
& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-$ydrolyed Tc (mTc-).
Results:
% 99mTc-/,3 = 100 (%99mTcO4- ! %99mTcO2-)
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 14/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM8
99mTc-/a3
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y*ytem %Pur$ty %+m#ur$ty
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 15/28
1
2
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM9
99mTc-/DP
Procedure:System I: ITLC-SG / Acetone (HPLC grade)
System II: ITLC-SG / Saline (0.! "aCl)
#$ere%
% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I.
% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System
II
% 99mTc-/DP & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate
(mTc*-) or%
& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-
$ydrolyed Tc (mTc-).
Results:% 99mTc-/DP = 100 (%99mTcO4- ! %99mTcO2
-)
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 16/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
NM9
99mTc-/DPDate " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 17/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
99mTc-/+.+
Procedure:An acc,rate aer c$romatogra$y roced,re introd,ced 3y Patel et al7 (1996) can 3e
alied to searate mTc-I6I rom ot$er im,rities. 8hatman 3// #a#er stris
are ,sed as stationary $ase and 9979% ethyl acetate as sol'ent.
#$ere%
% 99mTc-/+.+ & ! acti'ity at t$e sol'ent ront (+ & 0.77-0.=7)
% Pertechnetate (99mTcO4-) ! % Reduced-hydrolyzed Tc (99mTcO2-) = (! acti'ity
remaining at t$e origin (+ & 0.0-0.;).
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 18/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
99m
Tc-/+.+Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
Samle ;
Samle
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
Samle ;
Samle
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
Samle ;
Samle
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
Samle ;
Samle
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 19/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
99mTc-anocollo$d
Procedure:S,ita3le aer c$romatogra$y roced,re can 3e ,sed to searate mTc-"anocolloid
rom ree ertec$netate. 8hatman &T-31stris are ,sed as stationary $ase and
079% al as sol'ent.
#$ere%
% 99mTc-Pertechnetate & ! acti'ity at t$e sol'ent ront (+ & ;.0)
%99m
Tc-anocollo$d and % Reduced-hydrolyzed Tc (99m
TcO2-
) = (! acti'ityremaining at t$e origin (+ & 0.0).
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 20/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
99m
Tc-anocollo$d
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 21/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
99mTc-Pertechnetate Procedure:An acc,rate aer c$romatogra$y roced,re can 3e alied to searate mTc-
Pertec$netate rom ot$er im,rities. +T-* stris are ,sed as stationary $ase and
/ethyl &thyl 5eton(/&5) as sol'ent.
#$ere%
% 99mTc-Pertechnetate & ! acti'ity at t$e sol'ent ront (+ & 0.-;.0)
% Reduced-hydrolyzed Tc (99mTcO2-) and other $m#ur$t$e = (! acti'ity remaining
at t$e origin (+ & 0.0-0.;).
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 22/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
99m
Tc-PertechnetateDate " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 23/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
99mTc-Pyro#ho#hate
Procedure:System I: ITLC-SG / Acetone (HPLC grade)
System II: ITLC-SG / Saline (0.! "aCl)
#$ere%
% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I.
% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System
II
% 99mTc- P:P & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate
(mTc*-) or%
& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-
$ydrolyed Tc (mTc-).
Results:
% 99mTc- P:P = 100 (%99mTcO4- ! %99mTcO2-)
Medical Imaging Department
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 24/28
Nuclear Medicine Section
Radiopharmaceutical QA Program
99mTc-Pyro#ho#hate
Date " Pre#arat$on t$me "$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 25/28
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
99mTc-*ul;ur ollo$d
Procedure:Proer aer c$romatogra$y roced,re can 3e ,sed to searate mTc-SC rom ree
ertec$netate. +T-* stris are ,sed as stationary $ase and ,cetone (HP
rade) as sol'ent.
#$ere%
% 99mTc-Pertechnetate & ! acti'ity at t$e sol'ent ront (+ & ;.0)
% 99mTc-* and % Reduced-hydrolyzed Tc (99mTcO2-) = (! acti'ity remaining at
t$e origin (+ & 0.0).
Medical Imaging Department
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 26/28
Nuclear Medicine Section
Radiopharmaceutical QA Program
99mTc-*ul;ur ollo$dDate " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
1
2
Medical Imaging Department
Nuclear Medicine Section
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 27/28
Radiopharmaceutical QA Program
NML-1
99mTc-Tetro;om$n (/yo$e<)
>ate : Prearation time :
?ial lot no : 19ire date:
Statonar! P"ase:
#$atman "o.;
#o$le P"ase:
1t$yl Acetate .!
Procedure:#$atman "0.;/ 1t$yl Acetate miniat,ried system can 3e ,sed s,ccess,lly to
searate t$e la3eled comle9 (mTc-Tetroosmin)% 4$ic$ migrates to t$e sol'ent ront
(+ & 0.*-0.@) rom t$e la3eling im,rities 4$ic$ remain at t$e origin (+ & 0.0- 0.;) .
Medical Imaging Department
Nuclear Medicine Section
Radiopharmaceutical QA Program
99m
Tc-Tetro;om$n (/yo$e<)
7/23/2019 Qc Rp Kits (Mid Kfsh d)
http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 28/28
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
Samle ;
Samle
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
Samle ;
Samle
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
Samle ;
Samle
Date " Pre#arat$on t$me "
$al lot no " &'#$re date:
Reult %RP PH ,##roal .y
*ytem %Pur$ty %+m#ur$ty
Samle ;
Samle